Showing posts with label Psychiatry. Show all posts
Showing posts with label Psychiatry. Show all posts

Sunday, June 08, 2008

Health Tip: Taking a Mental Status Test

(HealthDay News) -- Mental status tests are given to determine the state of a person's mental health. The test, for example, can help gauge the mental progression of a physical illness such as Alzheimer's disease.

Here's what may comprise a mental status test, courtesy of the U.S. National Library of Medicine:
  • An examination of physical appearance, including dress and grooming.
  • Orientation and awareness -- knowing one's own name, address, and phone, as well as the current date and season.
  • Length of attention span, and short-term and long-term memory.
  • Tests to determine abilities including problem solving and judgment.
  • Ability to identify objects and recall words.

Thursday, February 14, 2008

Marijuana Use Among MS Patients Raises Risk for Cognitive, Mood Problems

(HealthDay News) -- Multiple sclerosis patients who smoke marijuana in search of symptom relief are more likely to suffer cognitive shortfalls and mood disorders, new Canadian research suggests.

A slowing down in the ability to process and remember information is one significant side effect, as is a rise in the rate of depression and anxiety.

"This is a small study, so our findings are preliminary, but the bottom line is that multiple sclerosis patients who smoke cannabis appear to be at an increased risk for cognitive issues, particularly with respect to the speed of their thinking," said study author Dr. Anthony Feinstein, a professor of psychiatry with the Sunnybrook Health Sciences Centre's department of psychiatry at the University of Toronto.

Feinstein's observations are published in the Feb. 13 online edition of Neurology and are focused exclusively on the impact of smoking marijuana illegally obtained by patients themselves. Medically prescribed marijuana was not studied.

The authors noted that a "significant minority" of multiple sclerosis patients smoke marijuana to combat the tingling, numbness, blindness and paralysis that can accompany the progressive and often disabling nervous system disease.

However, Feinstein's team stressed that scientists have yet to definitively prove that the psychoactive substance -- long linked to psychosis, anxiety and delirium among healthy users -- provides a measurable benefit to the more than 400,000 Americans and 2.5 million people worldwide who suffer from the disease.

The researchers therefore assessed the experience of 140 Toronto-based MS outpatients, 10 of whom had smoked the drug at least once in the previous month and were considered regular marijuana users.

All the patients -- three-quarters of them women -- underwent cognitive and mental health exams by a neurologist and a neuro-psychiatrist. Interviews were also conducted to assess disease severity and course, medications being used, and current disability.

Feinstein and his team observed that while pot smokers were younger, there were no differences between marijuana users and nonusers in terms of gender, education, or MS disease course or duration.

However, MS patients who used marijuana were found to perform 50 percent slower on tests tracking information-processing speed and were more likely than nonusers to have a mental disability of some kind.

Marijuana use was also associated with a greater risk for being depressed or experiencing anxiety. However, the authors were not able to determine whether the drug had triggered such conditions, or if patients had sought out marijuana to help deal with a preexisting emotional issue.

They nonetheless cautioned that smoking marijuana might further raise the risk for experiencing the kind of neuro-psychological impairment that typically occurs among 40 percent to 65 percent of all MS patients.

Feinstein said that he next hopes to gather a much larger pool of patients, while exploring possible differences in the health impact of street-purchased marijuana versus prescribed cannabis.

Meanwhile, Dr. Marshall Keilson, director of neurology at Maimonides Medical Center in Brooklyn, N.Y., said he thinks it best to proceed on a case-by-case basis.

"There are some MS patients who are emotionally disabled from their disease, and if we can use cannabis to help them feel better about the world or life, we should," he said. "We need to always err on the side of doing what's best for our patients. And I don't necessarily believe there is a permanent damage to the brain, based on occasional marijuana use. If they're smoking 10 times a day, yes, there will be damage done. But this goes for excessive alcohol use, too. So, I think we're going to end up somewhere in the middle with this."

More information
For more on multiple sclerosis, visit the National Multiple Sclerosis Society.

Thursday, January 03, 2008

Relatives of Parkinson's Patients at Higher Psychiatric Risk

(HealthDay News) -- The close relatives of people with Parkinson's disease are at increased risk for depression and anxiety disorders, new research suggests.

The risk is particularly high in the brothers, sisters, parents and children of people who develop Parkinson's before age 75, said a team from the Mayo Clinic in Rochester, Minn.

The study included 1,000 immediate relatives of 162 Parkinson's patients and 850 immediate relatives of 147 people without Parkinson's. It's the first large population-based study to identify this kind of association.

"Studies by our group and others have shown that relatives of patients with Parkinson's disease have an increased risk of Parkinson's disease. Recently, we showed they also have increased risk of essential tremor and of cognitive impairment or dementia. However, the risk of psychiatric disorders was unknown," senior author Dr. Walter Rocca, a neurologist and epidemiologist, said in a prepared statement.

"Because many patients with Parkinson's disease develop anxiety and depression after and even before the onset of the disease, we explored whether this tendency was present to a greater extent in family members of people with Parkinson's disease compared with people without the disease. We found that, indeed, relatives of patients with Parkinson's disease are at increased risk for anxiety and depressive disorders, which suggests a genetic or other relationship between those disorders and Parkinson's disease," Rocca said.

Further research is needed to determine the exact cause or causes that boost the risk, he said.

The study was published in the December issue of the journal Archives of General Psychiatry.

More information
There's more on Parkinson's disease at We Move.

Saturday, November 24, 2007

Sleep Problems Plague the Older Set

(HealthDay News) -- Older Americans often have difficulty getting a good night's rest. It's a huge quality-of-life problem, experts say, because contrary to popular belief, seniors require about the same amount of sleep as younger adults.

"Sleep problems and sleep disorders are not an inherent part of aging," said Dr. Harrison G. Bloom, a senior associate at the International Longevity Center-USA and associate clinical professor of geriatrics and medicine at the Mount Sinai School of Medicine in New York City.
"It's pretty much of a myth that older people need less sleep than younger people."

Yet, in a study published recently in The American Journal of Medicine, researchers found that more than half of older Americans have problems getting the shuteye they need.

Older people tend to have "sleep fragmentation," meaning they wake up more often during the night, said study author Dr. Julie Gammack, an assistant professor of medicine in the Division of Geriatric Medicine at St. Louis University.

They also seem to get less "REM" sleep, the type of sleep during which rapid eye movement occurs, Bloom added.

It's unclear what role these naturally occurring changes in sleep patterns have on a person's quality of life, Bloom said. "What is important, though, is that older people often have actual sleep disorders and problems with sleep," he said.

And, experts say, there is usually more than one cause.

"Sleep disturbance in older adults is typically associated with acute and chronic illnesses, including specific sleep disorders like sleep apnea and restless leg syndrome that appear with greater frequency in older populations," said Michael V. Vitiello, a professor of psychiatry and behavioral sciences and associate director of the University of Washington's Northwest Geriatric Education Center.

As people age, they typically develop more diseases and suffer from aches and pains. "These things can disrupt sleep, so what they may perceive as a sleep disorder may actually relate to the effects of some of their other medical problems," Gammack noted.

Taking multiple medications, as many older people do, can also lead to fatigue and "hypersomnia," or being tired all the time, Bloom added.

Another big problem, he noted, is depression and anxiety. "Those are very commonly associated with sleep problems."

Despite the prevalence of sleep difficulties in older adults, many patients aren't getting the help they need.

"The average physician receives very little training about sleep disorders and typically does not routinely screen patients for them," said Vitiello, who serves on the board of directors of the National Sleep Foundation. This may be due to a lack of time or training or the belief that there is little that can be done to improve sleep, he explained.

As a result, problems like insomnia, restless leg syndrome, sleep apnea and circadian rhythm disorders are underdiagnosed and undertreated, Bloom said.

To rectify the problem, a national coalition of aging, geriatric medicine and sleep organizations is currently developing guidelines to promote prevention, diagnosis and treatment of sleep problems in older adults. The National Coalition for Sleep Disorders in Older People expects to publish its recommendations by mid-2008.

"The reason we're concerned with these [problems], besides a major issue on quality of life and being tired the next day and not functioning properly, is that these sleep disorders are associated with hypertension, diabetes, pulmonary disease, heart disease, depression and anxiety," said Bloom, chairman of coalition's expert task force.

A cause-and-effect relationship has yet to be established between sleep disorders and these chronic health problems, but Bloom suspects they at least contribute to each other. And he believes a causal relationship may be found in years to come.

"This is very, very much a tip-of-the-iceberg problem," he said.

More information
For tips on better sleep, visit the National Sleep Foundation.

Wednesday, November 14, 2007

Follow-Up Exams Uncover More Iraq Vets With Emotional Woes

(HealthDay News) -- The number of Iraq war veterans needing mental-health care has risen sharply since the U.S. Defense Department began screening them a second time for emotional problems, U.S. military researchers reported Tuesday.

Initial screenings of veterans uncovered 4.4 percent who needed treatment for problems such as depression or post-traumatic stress disorder (PTSD). But six months later, a second screening found 11.7 percent were in need of mental health care, indicating that it might take several months for emotional disorders to emerge, the study suggested.

"We know mental health problems are a problem for soldiers who have been to war," said lead researcher Dr. Charles S. Milliken, of the Walter Reed Army Institute of Research at the U.S. Army Medical Research and Materiel Command. "We are doing a good thing by having erected these screening programs. Between the two screenings, we are finding a large group of soldiers that are having problems."

The findings are published in the Nov. 14 issue of the Journal of the American Medical Association.

For the study, Milliken and his colleagues collected data on the mental health of 88,235 Iraq war veterans who completed an initial screening and a second screening about six months later. Both screenings included a questionnaire and a short interview with a clinician.

"In the second screening, you do find a larger group of soldiers the first screening completely missed," Milliken said. "It's about twice as big."

The researchers found that more soldiers had mental health problems -- such as PTSD, major depression or alcohol abuse -- during the later screening. In the first screening, 4.4 percent of the soldiers were referred for mental health care, but, after the second screening, 11.7 percent were referred.

Milliken thinks the two-step screening process helps remove the stigma attached to seeking help for emotional problems. "Soldiers are like other young males, they have a stigma about seeking mental health care," he said.

Among all the soldiers screened, 20.3 percent of active duty personnel were referred for mental health care, as were 42.4 percent of reserve soldiers, the study found.

Milliken said he didn't know why the difference exists between the active duty soldiers and the reservists. He speculated, however, that it might have to do with the VA's insurance structure that allows reservists access to free care for service-related health problems.

One expert thinks the new, two-tier system for identifying soldiers with emotional problems is working, but the shear numbers of affected veterans could overburden the VA's health-care system.

"I am not surprised by the rates of PTSD among Iraqi vets," said Dr. Randall Marshall, director of Trauma Studies at the New York State Psychiatric Institute and an associate professor of clinical psychiatry at Columbia University College of Physicians and Surgeons.

Marshall said the difference in PTSD rates among active duty and reserve personnel is expected. "Part of what training is meant to do is desensitize soldiers to all the potential experiences on the battlefield, and the reservists have less training and are therefore more vulnerable to war experiences," he said.

Marshall also said that many reservists have had several tours of duty, "which is something they had not signed up for."

Also, many of these part-time soldiers were split from their units, which means they didn't have as much of a support system as active duty personnel, he said.

Marshall sees another major problem developing for returning veterans. Most psychotherapists aren't trained in the best ways to treat PTSD, he said. "You can't assume because it's a VA hospital everyone there has had this kind of training," he said.

In addition, the number of soldiers needing mental health care is straining an already overburdened system.
"If 20 percent of the veterans realize they need help and start to seek treatment, the system will be overwhelmed. Signs are, it already is," Marshall said.

More information
To learn more, visit the U.S. Department of Veterans Affairs.

Monday, August 20, 2007

Does Pathological Shyness Make for School Shooters?

(HealthDay News) -- What motivates some teens to gun down fellow students in the hallways or grounds of their schools?

Perhaps a characteristic called "cynical shyness." This is an extreme form of shyness affecting mostly males that can lead to violent behavior such as that seen at Columbine, Colo., or, most recently, Virginia Tech, according to researchers who were to present their findings Saturday evening at the American Psychological Association's annual meeting, in San Francisco.

"Cynically shy people are shy people who are motivated toward moving to others, and then they are rejected," said Bernardo Carducci, lead author of the study and director of the Shyness Research Institute at Indiana University Southeast in New Albany.

"In addition to feelings of anxiety about social situations, cynically shy people, who are a small subclass of shy people, also have feelings of anger and hostility toward others and that comes from this sense of disconnect," Carducci explained. "Shyness has more in common with extroversion than with introversion. Shy people truly want to be with others, so they make the effort, but when they are rejected or ostracized, they disconnect. Once you disconnect, it's very easy to start being angry and hate other people. It's you against them, and they become what I call a cult of one. Once you start thinking 'it's me versus them,' then it becomes easy to start hurting these people."

Eventually, the new research may help identify the likely perpetrators of such crimes before they happen, the study authors said.

"It would be great if we could better characterize people who might be likely to do something violent," said Dr. Jane Ripperger-Suhler, assistant professor of psychiatry and behavioral science at the Texas A&M Health Science Center College of Medicine and a psychiatrist with Scott & White Mental Health Center in Temple. "Right now, our ability to predict violence is not very good at all, so people overreact to a lot of things because of a fear of something happening.

For years, we were under-reacting. It would be nice if psychologists could help us characterize who would be more likely to be a school shooter."

But it's important not to stigmatize shy kids, other experts emphasized.
"Shyness is not inherently a good or bad thing," said Heather Henderson, assistant professor of psychology at the University of Miami. "But one thing we know about shyness in boys, particularly in North America, they seem to be particularly at risk for maladaptive outcomes.

We expect boys to be more outgoing and assertive. Boys are particularly sensitive and are exposed to cues from other people that shyness is not a good thing."
According to the study authors, there are a number of subtypes of shyness, cynical shyness being just one.
For the study, Carducci and a co-author examined news accounts and background information on seven high school shooting cases involving eight teen shooters between 1995 and 2004.

Those individuals were:
Jeffrey Weise -- 16, killed seven people at Red Lake High School in Minnesota as well as his grandfather and grandfather's girlfriend in 2005;

Jamie Rouse -- 17, killed one student and one teacher at Richland High School in Tennessee in 1995;

Luke Woodham -- 17, killed two people at Pearl High School in Mississippi in 1997;
Barry Loukaitis -- 14, killed three at Frontier Junior High in Washington state in 1996;
Eric Harris and Dylan Klebold -- 18 and 17 years old, they killed 12 students and a teacher at Columbine High School in Colorado in 1999;

Michael Carneal -- 14, killed three girls at Heath High School in Kentucky in 1997;
Kip Kinkel -- 15, killed his parents and two classmates at Thurston High School in Oregon in 1998.

Weise, the two Columbine killers and Kinkel had a "cynically shy score" of 10 (on a scale of 10). Rouse, Woodham and Loukaitis had scores of 8, and Carneal had a score of 6, the researchers said.

Cynically shy people tend to be male and want to relate to other people but just don't know how. As a result, they get rejected, and feelings of hurt gradually turn into intense rage, the study authors said.

This seems to be an extreme version of the frustrations other shy people often face.
"We often misinterpret why people are shy," Henderson said. "If you walk by somebody and avoid eye contact, you interpret that as they don't want to interact, but I think often it's completely the opposite. They really do want to interact and don't know how.

"It's important for parents and teachers to start at a young age, before the person is walking down the high school corridor ready to shoot, not to interpret their behavior as not wanting to interact," Henderson continued. "If we flip our interpretations, people may respond differently.

As a field, we need to understand prospectively what's happening, so we can start identifying kids at a very young age, what would drive a shy kid into this pattern. We don't want the message to be 'shyness will lead to shooting.' "

More information
To learn more, visit the Center for the Prevention of School Violence.

Tuesday, July 24, 2007

Gene May Help Spur Premenstrual Depression

(HealthDay News) -- Scientists have discovered a gene variant linked to an increased risk of severe premenstrual depression.

Premenstrual dysphoric disorder, or PMDD, is a psychiatric condition that affects about 8 percent of women in their childbearing years. Women with PMDD experience bouts of major depression and/or anxiety and severe irritability during the second half of their menstrual cycle.

These symptoms subside with the onset of the menstrual period.

PMDD has been thought to be related to hormonal changes over the course of the menstrual cycle.

For a new study published online June 30 in Biological Psychiatry, researchers studied 91 women with a confirmed diagnosis of PMDD over at least three months. Another 56 women who had no history of mood disorders related to the menstrual cycle served as the comparison group.

The team found four specific gene variants in the estrogen receptor alpha gene, ESR1, that were more common in the women with PMDD than in the control group.

"While these are preliminary findings that require replication in larger studies, we would argue that this may explain part of the variance among women in the susceptibility to developing this mood disorder," the study's senior author David R. Rubinow, Meymandi distinguished professor and chair of psychiatry at the University of North Carolina School of Medicine, said in a prepared statement.

More information
The American Academy of Family Physicians has more about PMDD.

Saturday, June 02, 2007

Sex While Asleep Not Just Dreamed Up

(HealthDay News) -- After uncovering the secret lives of people who walk, eat and become aggressive while asleep, scientists are now turning to another bedtime phenomenon: "sleepsex."

Reports of sexual behavior while asleep have become so common that experts on Friday released a classification system that allows doctors to better document these cases.

People who engage in sleepsex "don't remember what they do, and it's their bed partners who tell them. They're mortified, and the partner complains they're being assaulted or molested," said Dr. Carlos Schenck, a sleep researcher who was lead author on the report. "Now they'll realize this is a sleep-related disorder."

Since the 1990s, researchers have been exploring the range of "parasomnia" behaviors in which people do things other than sleep while sleeping.

Sleepwalking, of course, is nothing new -- ask Lady Macbeth -- but researchers are discovering that people eat while asleep, engage in violence, and even intensely scratch themselves.

"Anything that people do during the daytime, we're realizing they can do during sleep, all the instinctual or basic behaviors," Schenck, an associate professor of psychiatry at the University of Minnesota Medical School, said.

Schenck and colleagues explored existing reports of sexual behavior during sleep and created the classification system. Their work appears in the June issue of the journal Sleep.

The researchers looked at 31 cases of sleep-related sexual behavior. They found that 80 percent involved men. Only males engaged in sleep sexual intercourse (42 percent of cases) while females were more likely to engage in "sexual vocalizations." People of both genders reported incidents of sleep masturbation.

In one case, they reported, "a 28-year-old woman had nightly sexual moaning and sexual fondling during sleep for 16 years that would appear within 20 minutes of falling asleep and disturb the sleep of her husband and children."

In another case, a 26-year-old woman would initiate foreplay with her bed partner during sleep and then awaken and accuse him of forcing sex upon her.

None of the patients reported remembering the incidents.

Patients who have sex while asleep typically do not have any form of mental disorders, Schenck said. "Basically, an alarm rings in their nervous system when it shouldn't ring, and they have this partial awakening. It's a twilight state," he said.

Unfortunately for the patients, "they have suspended judgment," Schenck said. "They can't monitor themselves, and they're are risk for harming themselves or someone else."

In many cases, he added, bed partners reported unwanted sexual advances by a sleeping person, but sometime said they didn't mind the extra attention.

The sedative clonazepam (Klonopin) is a frequent treatment for unwanted behaviors during sleep and it works in 90 percent of parasomnia cases, according to the new report.

It's not clear how common sleepsex is. Dr. Robert Vorona, a sleep researcher and associate professor of internal medicine at Eastern Virginia Medical School, suspects that the true number of cases is not on the rise.

"However, until sleep specialists actively question our patients about these delicate issues, we will not really know just how common or uncommon these behaviors might be, or whether these activities might be occurring more frequently," he said.

As for the future, he said sleep experts -- already called as experts in court cases on violence reportedly taking place during sleep -- may find themselves testifying even more often.

"Sleep clinicians should not be surprised to find themselves increasingly being asked to testify in controversial cases involving sexual activity during sleep," he said.

More information
To learn more about sleep disorders try the National Library of Medicine.

Wednesday, April 18, 2007

Antidepressants Help More Kids Than They Harm

(HealthDay News) -- Whether depressed or troubled kids should take antidepressants has been the question at the center of an intense public debate in recent years, and the latest evidence suggests the answer is "yes."

A study in the April 18 issue of the Journal of the American Medical Association found that the benefits of antidepressants outweighed the risks for children and adolescents under the age of 19.

Anecdotal reports released over the past few years suggest that antidepressants raise suicide risk in children and teens. But the drugs may also prevent deaths by curbing depression, experts say.

"Our study shows that, at least in the short-term, treatment benefits appear to outweigh the risks," confirmed study author Jeffrey A. Bridge, an investigator with Columbus Children's Research Institute, in Ohio.

The findings seem to tip the scale more in favor of antidepressants, which include widely used selective serotonin reuptake inhibitors (SSRIs) such as Celexa, Paxil, Prozac and Zoloft.

"They're saying that, yes, there is a slightly increased risk but it's not as big as we thought and the risk-benefit ratio is favorable. But that's a decision that every family has to make. It's not a generalized decision," said Dr. Jane Ripperger-Suhler, an assistant professor of psychiatry and behavioral science at Texas A&M Health Science Center College of Medicine and a psychiatrist with Scott & White Mental Health Center in Temple.

"This leans us more toward the middle -- that we don't have to say these are terrible medicines, that this looks like a fairly good option. and let's not take them off the table," she said.
Antidepressants, particularly SSRIs, have been the subject of intense controversy in recent years.

In October 2003, the U.S. Food and Drug Administration issued a public health advisory, warning of an increased risk of suicide attempts or suicide-related behavior among children and teens taking SSRIs.

One year later, the FDA directed manufacturers of those drugs to revise their labeling to include a black-box warning. The warning alerts health-care providers to an increased risk of suicide and suicidal thoughts in children and teens.

On the other side of the argument, a major new study found that SSRIs have actually saved thousands of lives by preventing suicides since they were introduced in 1988.

The negative press SSRIs received may have had a chilling effect on their use in the pediatric population, however. One recent study found that the number of U.S. children being prescribed the antidepressants has dropped since warnings about suicidal behavior associated with the drugs emerged. This trend could be worrisome if it means that young patients who might benefit from SSRIs aren't getting them, experts have said.

The only SSRI approved by the FDA for use in pediatric patients is Prozac, but others are prescribed on an off-label basis.

In 2004, an FDA review of 24 placebo-controlled trials involving antidepressant medication in more than 4,400 children and adolescents found that the medications spurred a twofold (4 percent vs. 2 percent) increased risk for suicidal behavior or ideation (thoughts of suicide), although no completed suicides were reported.

The current paper was a large review of all of the published and unpublished randomized clinical trials involving the use of antidepressants by children and adolescents younger than 19. The youngsters were being treated for major depressive disorder (MDD), obsessive-compulsive disorder (OCD) and anxiety disorders other than OCD. In all, 27 trials were reviewed and 5,310 patients were followed.

For every 100 children and adolescents treated with antidepressants, about one child would have thoughts of suicide or would attempt suicide beyond the risk associated with the underlying condition, the researchers found.

This was a number that was lower than the FDA's review, which found two instances of suicidal ideation or attempted suicide per 100 patients.

The study also found that the only antidepressant effective in treating depression in children under 12 was Prozac. Several medications were effective in older children.
The effects of the drugs were most pronounced for non-OCD anxiety disorders, followed by OCD and then MDD.

But the new findings are unlikely to be the last word on the subject.
"There are a few studies that are ongoing right now and that will certainly inform our findings," Bridge said.

"It doesn't seem like they have resolved the issue completely," added Ripperger-Suhler. "I'm hoping that someone will do a prospective study."

More information about Depression

Sunday, November 19, 2006

ADHD Drug to Get Stronger Warning

(HealthDay News) -- U.S. officials have asked a pharmaceutical company to add a label warning of a risk for heart problems for patients taking the prescription drug Dexedrine, a stimulant used to treat attention-deficit hyperactivity disorder (ADHD).

The warning describes some instances of sudden death in children and teens with structural cardiac abnormalities or other heart problems. It also mentions various potential psychological side effects, including hallucinations or delusional thinking.

The U.S. Food and Drug Administration could not be reached for comment, and it was unclear what other ADHD drugs might be affected by this new warning.

Back in May, the FDA had asked makers of similar stimulant ADHD drugs to add the warnings.
"This had already been done with other stimulants," said Dr. Melvin Oatis, an assistant professor of clinical psychiatry at New York University School of Medicine's Child Study Center. "Dexedrine is in an older class of stimulant,s and not much new had been done with that."
A letter sent from Dexedrine's maker, GlaxoSmithKline, to health-care providers was posted Tuesday on the FDA's Web site. The letter detailed the planned changes to prescription recommendations.

In March, an FDA pediatric advisory committee had recommended that ADHD drugs not carry the more severe "black-box" warnings and instead use simpler language and include more information on the labels about the heart risks posed by the drugs. But the month before, a different FDA advisory committee had reached the opposite conclusion, and called for a black-box warning on ADHD drugs because of possible cardiac risks.

The FDA has apparently settled for the less-severe advisory.

"This is not a black-box warning," Oatis said. "There's some association [between Dexedrine and heart problems]. They're not making this a causality."

An estimated 2.5 million American children under the age of 19 take ADHD drugs, as do 1.5 million adults.

This represents a huge surge in use, experts said.

"ADHD is being recognized more often than it was before," said Dr. Eugenio Rothe, an associate professor of psychiatry at the University of Miami Miller School of Medicine, and director of the child and adolescent psychiatry clinic at Jackson Memorial Hospital. "When the disorder is being recognized more often, obviously there's more use of medication," he said.

In addition to "serious" cardiovascular side effects, the warnings issued since last spring cite possible suppression of children's growth, as well as heightened risks for psychosis, Bipolar disorder and aggression.

The revisions may have an effect on prescribing patterns, Rothe said.

"On the one hand, it may actually help pediatricians and even some psychiatrists be more careful," Rothe said. "But, on the other hand, it scares people away from getting treatment and also increases the amount of time that one has to spend with parents trying to convince them this is the right thing to do. Doctors are already stretched thin."

Oatis added that the new warning "should remind clinicians to review the side-effect profiles of medications. It reminds you to take more of a history of family issues regarding stimulant use and medical cardiac risk."

According to the U.S. National Institutes of Health, ADHD is a disorder characterized by inattention, hyperactivity and impulsivity. These symptoms typically appear early in a child's life. However, many healthy children may have these symptoms, but only at a low level, or the symptoms may be caused by another disorder. For that reason, many experts believe it is important the child receive a thorough examination and appropriate diagnosis by a qualified professional.

More information
The National Institute of Mental Health has more on ADHD.

Friday, October 20, 2006

Marijuana-Like Compound May Slow Alzheimer's

(HealthDay News) -- A new U.S. study finds that marijuana may help slow the progression of Alzheimer's, while a second report suggests the "club drug" Ecstasy could yield insights into Parkinson's disease.

Both findings were presented Wednesday at the annual meeting of the Society for Neuroscience, in Atlanta.

In the first presentation, researchers from Ohio State University in Columbus found that marijuana may contain compounds that can slow memory loss associated with Alzheimer's disease.

In their study involving rats, a team led by psychology professor Gary Wenk searched for ways to reduce Alzheimer's-linked brain inflammation.

Wenk was already familiar with data that found that long-term marijuana users had lower rates of Alzheimer's disease than the general population. His team sought to find a compound that might reduce disease-linked brain inflammation but avoid the drug's psychoactive effects.
"We are using a component of marijuana that stimulates the same centers in the brain that marijuana does," Wenk said. The synthetic compound, which is very similar in composition to marijuana, is called WIN-55212-2 (WIN).

Experiments conducted on young and old rats revealed that WIN is "a very effective anti-inflammatory, it reduces brain inflammation," Wenk said.

What makes this discovery special is that this compound can cross the blood-brain barrier, Wenk explained. The results of a special rat "maze test" suggested that WIN "also reversed the memory impairment in the older rats," he said.

Brain inflammation is characteristic of many diseases other than Alzheimer's, including multiple sclerosis, ALS, AIDS, Huntington's and Parkinson's, Wenk noted. "We are beginning to notice that brain inflammation is always in the background as people get older," he said. "Inflammation doesn't cause the disease, it contributes to the pathology," he said.

WIN is not appropriate for use in humans because it still contains substances that may trigger a "high." However, Wenk hopes that some form of this compound might be used to benefit people with neurological diseases.

"We have the added advantage that millions of doses [of marijuana] have been taken by millions of people over the past centuries," he said. "We already know a lot about its actions in the body and its toxicity, or lack of toxicity. The only problem we have is that it's illegal."

Wenk is not suggesting that Alzheimer's patients start using marijuana. "Patients would have to be so careful not to get too much," he said. "That would only worsen the symptoms of their dementia."
The challenge is to find a dose that has an anti-inflammatory effect but does not make patients high, Wenk said. "It's hopeful," he said, "but it's not a therapy until we find a way to make it work in humans."

One expert believes it may be possible to derive therapeutic benefits from marijuana without inducing other effects that could be harmful to Alzheimer's patients.

"These are still early days for thinking about drugs derived from cannabis," said Dr. Samuel Gandy, director of the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia.
"Still, we know the structure of tetrahydrocannabinol (THC) [the active ingredient in cannabis] in detail, and it is not inconceivable that helpful THC-based drugs could be created chemically that benefit brain function but lack the 'high' that currently stigmatizes the compound," Gandy added.

In the second report, researchers from the University of Cincinnati found that, in rats, MDMA (methylenedioxymethamphetamine) -- more commonly known as the illegal drug Ecstasy -- increases the survival of dopamine-releasing cells in the brain during fetal development.
"The club drug Ecstasy can cause dopamine neurons to grow and prevent them from dying off," explained lead researcher Jack Lipton, a professor of psychiatry.

Dopamine cells are critical to the regulation of voluntary movement. This discovery might lead to better therapies for neurological diseases such as Parkinson's, the researchers said.
Ecstasy, as is, is not beneficial for Parkinson's patients, Lipton cautioned. But a part of MDMA may be.

The trick now is to find the components of MDMA that have this effect on dopamine cells and develop ways to use it to help Parkinson's patients, Lipton said. It could also be used as an adjunct to stem cell transplantation, something that's now being studied in Parkinson's patients.
"It could help transplants take better and have more cells survive," Lipton said.

More information
There's more on Alzheimer's disease at the Alzheimer's Association.

Sunday, October 08, 2006

PTSD Can Take Months to Strike Wounded Iraq and Afghanistan Vets

(HealthDay News) -- Soldiers wounded during combat in Iraq and Afghanistan often develop post-traumatic stress disorder and depression months after getting out of a hospital, instead of soon after suffering their injuries, a new study found.

And the severity of the injuries also helps predict the risk of developing post-traumatic stress disorder (PTSD) or depression.

It's not clear why it's taking more than half a year, in some cases, for symptoms of PTSD and depression to emerge. However, the study authors speculated that the concentrated treatments and therapies offered in a hospital may temporarily ward off psychological problems, leaving them to surface once a soldier has been released and comes to realize the extent of the injuries.
The report was published in the October issue of The American Journal of Psychiatry.

"The rates of PTSD and depression are much lower immediately following the injury than what we were expecting," said lead researcher Dr. Thomas A. Grieger, of the Uniformed Services University of the Health Sciences and Walter Reed Army Medical Center, in Washington, D.C. "We were expecting rates of around 20 percent."

Instead, Grieger and his colleagues found the initial rate of PTSD and depression was 4 percent. The researchers expected the rates of PTSD and depression to be controlled early, as is often the case with victims of automobile accidents. "In contrast, in this [military] population, the rates went up instead of down with time," he said.

For the study, the researchers screened 613 soldiers, who were severely wounded between March 2003 and September 2004. Of those, 243 completed health assessments at one, four, and seven months after their injuries. The rates of PTSD were 4 percent at one month, 12 percent at four months, and 12 percent at seven months. Rates of depression were 4.4 percent at one month, 9 percent at four months, and 9 percent at seven months.

Grieger noted that 78 percent of those soldiers with PTSD or depression at seven months showed no signs of either condition at one month. "There is a need for ongoing evaluation of the individuals that have had these sorts of exposures," he said.

The reasons for these findings aren't clear, Grieger said. He noted, however, that soldiers in a hospital are getting psychiatric care and medication, which may not be continued after the soldiers leave. "It may be that these symptoms come on after they leave the hospital because they are not continuing with their medications," he said. "It may also be that individuals don't report symptoms in the immediate aftermath of the injury."

Grieger further speculated that it's only when the soldiers return home and realize the full impact of their injuries on their lives that PTSD and depression strike.

One expert thinks this study could be helpful in designing programs to prevent and treat PTSD and depression in military personnel.

"Being wounded is a risk factor for PSTD," said Dr. Matthew J. Friedman, executive director of the Department of Veterans Affairs National Center for Post-Traumatic Stress Disorder.
Friedman believes it's important to understand why some soldiers recover from PTSD and depression when they struggle with it early, and why others develop these problems later. "This would enable us to do a better job of developing preventive approaches and trying to improve the situation for people following hospital discharge," he said.

Another researcher noted the rates of PTSD and depression seen among wounded soldiers returning from Iraq and Afghanistan are about the same as those seen among non-wounded soldiers.

"One of the important findings is that wounded soldiers did not have higher rates of PTSD than healthy soldiers surveyed using the same instruments and criteria," said Dr. Charles Hoge, who's with the department of psychiatry and behavioral sciences at Walter Reed Army Institute of Research. "This suggests that the preventive psychiatry services that wounded service members receive at Walter Reed has been effective in mitigating PTSD symptoms."

"The increase from 4 to 12 percent from one to four months is exactly what we've been seeing among non-wounded soldiers," Hoge added, who co-authored the new study. "We know that soldiers may not report mental-health symptoms until several months after they return home, and this study shows that this is true also among the wounded."

More information
The U.S. National Institute of Mental Health can tell you more about PTSD.

Monday, October 02, 2006

Mom-to-Daughter Gene May Help Spur Schizophrenia

(HealthDay News) -- Daughters with a specific immune gene that too closely resembles their mother's version of the gene are more likely to develop schizophrenia later in life, new research shows.
A developing fetus inherits one copy of the HLA-B gene from each parent. The HLA-B gene belongs to a family of genes that help the immune system distinguish between the body's own proteins and those made by viruses and bacteria.
In the study, researchers at the University of California, Los Angeles, analyzed DNA from 274 families, including a total of 484 children who'd been diagnosed with schizophrenia or a related disorder.
The study found that daughters whose HLA-B genes closely matched their mothers' HLA-B genes were 70 percent more likely to develop schizophrenia than other children. If this risk factor could be removed, up to 12 percent of cases of schizophrenia in daughters might be prevented, the researchers said.
The study is published in the October issue of the American Journal of Human Genetics.
"Our findings clearly suggest that schizophrenia risk rises, especially in daughters, when the child's HLA-B gene too closely matches its mother's. We don't know whether sons who match are not affected, or are more affected and less likely to come to term," Christina Palmer, UCLA associate professor of psychiatry and human genetics and a researcher at the Semel Institute for Neuroscience and Human Behavior, said in a prepared statement.
More information
The American Academy of Family Physicians has more about schizophrenia.

Sunday, May 21, 2006

Enterocolitis in Children With Developmental Disorders

Enterocolitis in Children With Developmental Disorders


Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomery SM, Davies S, O'Leary JJ, Phil D, Berelowitz M and Walker-Smith JA.

Introduction
We have recently described a characteristic pattern of intestinal inflammation in a cohort of children with developmental disorders (1). In these children, the majority of whom had autism,
a period of initial normal development was followed by developmental regression and loss of acquired skills, sometimes occurring precipitously over a period of days to weeks. Long-standing intestinal symptoms, as described previously (1), were typical of this group of children. These symptoms had often started at around the same time as the behavioral changes.

Ileocolonic lymphoid nodular hyperplasia (LNH) was a consistent feature of this condition, an observation that has been reported subsequently in children with attention deficit hyperactivity disorder (ADHD) and non-IgE-mediated food allergy (2). There is an anecdotal impression that LNH is a common finding in children undergoing ileocolonoscopy, although this has not been subjected to systematic analysis in a controlled study.

It cannot be assumed that LNH is a normal finding in children, as aymptomatic children are not subjected to ileocolonoscopy, and LNH may produce symptoms in its own right (3). Chronic intestinal LNH is a feature of either congenital or acquired immunodeficient states (4, 5, 6, 7, 8, 9, 10) and has been described in congenital B cell abnormalities (5, 6), and common variable immunodeficiency (7, 8). In its persistent acquired form, ileal LNH has been reported in association with infection with human immunodeficiency virus (HIV) before the development of AIDS (10).

The other consistent feature of the intestinal lesion was a mild-to-moderate colitis that lacked the specific diagnostic features of either Crohn's disease or ulcerative colitis (1). This combination of features, i.e., LNH and nonspecific colitis, indicates the possibility of chronic mucosal and/or systemic immune dysregulation. Systemic immunological abnormalities are not infrequent in children with autistic spectrum disorders (11, 12, 13, 14), although the origin and significance of the findings are uncertain. These immune changes, plus the presence of myelin basic protein (MBP) antibodies (15) and inhibition of macrophage migration to MBP (16), have led some workers to suggest that the behavioural syndrome may be associated with cerebral damage due to an autoimmune response to myelin or other structural components of the CNS (15, 16).

As part of our initial study (1) we undertook cerebral magnetic resonance imaging, EEG, and biochemical analysis of cerebrospinal fluid; none of these investigations indicated cerebral inflammation that would be consistent with autoimmune demyelination, although a more subtle lesion remains a possibility. Alternatively, others have proposed that some forms of autism may arise from the toxic effects of intestinal products on the developing brain (17, 18, 19), a situation that may have some overlap with hepatic enephalopathy. An early childhood enterocolitis would be more consistent with the latter mechanism.
This study sought to describe some of the characteristic endoscopic and histopathological features of this syndrome in a larger cohort of children with developmental disorders and intestinal symptoms, and to compare the findings with those in developmentally normal children undergoing ileocolonoscopy.

Materials and Methods
This study involved the analysis of data from 60 consecutive children with developmental disorders (affected children) including those 12 children described in a preliminary report (1). The median age of the children was 6 yr (range 3-16 yr) and 53 were boys, consistent with the male bias of developmental disorders (20). Developmental diagnoses in the affected children were autism (50 patients), Asperger's syndrome (five), disintegrative disorder (two), attention deficit hyperactivity disorder (ADHD) (one), and schizophrenia (one). The latter child was the oldest in the cohort, at 14 yr of age. The remaining child in this cohort, a girl 8 yr of age, had dyslexia and learning difficulties: she underwent developmental regression from approximately 54 months of age, which was associated with mouth ulcers, conjunctivitis, and severe constipation. Her developmental status is currently under investigation.

Autism is a behavioral syndrome that consists of qualitative impairments in social interaction and communication, with restrictive, repetitive, and stereotypic patterns of behavior. Delays or abnormal functioning in at least one of these areas occurs before the age of 3 yr. Asperger's syndrome is a high-functioning autistic spectrum disorder, and disintegrative disorder is a regressive condition occurring at age >3 yr in a previously normal child. Loss of acquired skills may occur precipitously or over a period of months. The behavioral features are similar to those of autism but may be accompanied by loss of bowel and bladder control (20).

The majority of affected children were white (57), but two were of Middle-Eastern origin, and one child had an Indian father and a white mother.

All but three affected children had a developmental disorder that was associated with a clear history of regression, with loss of acquired skills after 1 year of documented normal development (general practitioner/health visitor records).

In three cases, affected children who had been developmentally normal failed to progress beyond a certain point, but did not regress. All but one of the affected children had current intestinal symptoms consisting of abdominal pain pain, constipation, diarrhea (or alternating constipation and diarrhea), and bloating.

The one affected child who did not have current intestinal symptoms was investigated at his parents' and general practitioner's request. Affected children were consistently fastidious in their eating habits, with a diet limited largely to cereals, potato crisps, and bread. Despite this, they typically seemed well nourished, with anthropomorphic indices within normal limits. Certain foodstuffs such as dairy products were reported by parents to produce deterioration in behavior, whereas withholding such foods apparently produced behavioral improvement -- in particular, for aggression, eye contact, and sleep pattern. According to parental reports, recognizably undigested food was often seen in stools.

Discussion
These data both confirm and extend our original observations (1), and indicate a subtle and consistent pattern of intestinal pathology in this cohort of consecutively referred children. The combination of ileocolonic LNH and colitis in children with developmental disorders distinguished them from developmentally normal children with similar symptoms (including abdominal pain and constipation) in whom LNH and histopathological change were uncommon. These observations, in a broader diagnostic group of children with developmental/psychiatric disorders, and the recent report of Sabra et al. (2) of similar intestinal pathology in children with ADHD, suggests that the findings may be relevant more widely to childhood developmental disorders.

This study provides a quantitative assessment of a qualitative interpretation of histopathological changes in the ileocolonic mucosa. We have previously reported the quantitative assessment of cellular infiltration of the mucosa in biopsies from these children, employing immunohistochemistry and cell counting (22). That study confirmed the presence of a statistically significant increase in mucosal macrophage infiltrate and cells expressing class-II MHC antigen in biopsies from affected children, compared with normal controls.

Further quantitative studies have shown a statistically significant excess of CD3+, CD8+, and T cells, and of Syndecan-1+ plasma cells in the lamina propria, and evidence of increased epithelial proliferation in affected children compared with both normal children and those with chronic constipation (R. Furlano et al., submitted for publication). The pathology seems to reflect a subtle new variant of inflammatory bowel disease that lacks the specific diagnostic features of either Crohn's disease (e.g., granulomata) or ulcerative colitis (e.g., contiguous distal to proximal colonic inflammation).

The inflammatory features were accompanied by endoscopic changes and included a patchy, mild-to-moderate pancolitis, where (with the proviso that only mucosal biopsies were studied) they were confined to the upper lamina propria/epithelium. It is of possible clinical relevance that active disease in the ileum and colon was reflected systemically in a raised ESR and a neutrophil leucocytosis, respectively.

In view of the presenting symptoms in the affected children, the majority underwent ileocolonscopy rather than investigation of the upper gastrointestinal tract. However, Horvath et al. have recently reported compelling evidence of inflammatory changes in the esophagus, stomach, and duodenum in a majority of autistic children with symptoms similar to those described here (23). Where it is indicated, we have included upper endoscopy and biopsy in our protocol. Our initial findings are consistent with those of Horvath et al. and will be reported later.

The median age of affected children was lower than that in either of the two control groups. However, within the controls groups there was no relationship between age and either endoscopic or histopathological features of disease, indicating that the comparisons made here are valid. The natural history of this condition -- autistic enterocolitis -- is not known; because Crohn's disease and ulcerative colitis are rare in this age group, it is too soon to say whether or not the pathology will progress to a typical IBD phenotype.

It is notable that 68% of affected children had a lymphopenia. Immunological abnormalities are a recurring feature in studies of children with autism (25, 26), and detailed immunological studies of affected children will be reported as a follow-up to this report. Reactive follicular hyperplasia is an antigen-driven response (9). In a preliminary study, we have reported evidence of measles virus nucleocapsid protein in follicular dendritic cells of the reactive ileal lymphoid tissue and raised serum measles IgG immunoreactivity in some affected children (26). An association between measles virus, immunodysregulation, and autism was also suggested by the recent study by Singh et al. (27). Measles virus is recognized not only for its ability to establish persistent infection, but also to induce prolonged T helper cell, type II immune skewing and immunosuppression (28). The follicular dendritic cell would be an ideal location from which to mediate such a response (29).

It is tempting to suggest that a gut-brain interaction may be responsible for some of the behavioral features of this syndrome. Although the opioid excess hypothesis for autism was first proposed by Panksepp (17) in 1979, and reiterated independently by Reichelt et al. (18) and Shattock et al. (19), it has only recently found increasing acceptance in the pediatric psychiatry community. Opioid peptides of dietary origin, i.e., gliadomorphine and bovine casomorphine, have been identified in the urine of some of these children with autistic enterocolitis (unpublished observations), and the possible significance of these findings is under investigation.
In summary, an endoscopically and histologically consistent pattern of ileocolonic pathology has been identified in a cohort of children with developmental disorders. Reactive follicular hyperplasia, particularly prominent in the ileum, provides a focus for investigating the nature of antigen(s) that may be driving the intestinal inflammation in these children. This syndrome may reflect a subset of children with developmental disorders with distinct etiological and clinical features.
American Journal of Gastroenterology September 2000; 95: 2285-2295.

Monday, February 06, 2006

Everyone, including you, should check with a competent health care practitioner before using any medical therapy.

In 1991, another physician (in New York) came forward to me with his clinical ozone results. He wants no press. One of his staff members who was in the clinic every day and therefore could get the treatments every day was brought from HIV positive to HIV negative.

His T-cells went from 700 down to 150 as ozone killed off the diseased cells, and then back up to 1,100 as the body replaced them with fresh new healthy cells. Another MD, in a southern state who I interviewed stated he and a colleague collectively brought 9 people to HIV negative using a combination therapy that included ozone and DMSO. Neither will talk publicly. One had his house burned down and left the country.

In April of ((2, I interviewed DR. Eric Satori MD, and one of his cured AIDS patients. Dr. Satori told me the results he was getting with his own brand of direct IV ozone therapy which also includes mental conditioning. "To remove the reason the patient gets diseased." So far he has reported over 50 AIDS patients becoming virus free by combining subclavian heavy ozone treatments with vitamin, mineral, thymus, and homeopathic supplements. He reports he commonly gets results in only 12 days because he has been refining his therapy during 10 years of clinical research!

Everyone, including you, should check with a competent health care practitioner before using any medical therapy. But this time, first ask him "Have you had any actual hands-on training or clinical experience in any of the many ozone medical therapies?'

If your doctor is from the United States, the honest answer is always "No". So, how would your expert ever stick his liability laden neck out and approve of it? He should simply say, "I have no knowledge of it." But unfortunately his ego might reveal itself if he says "Well, I never heard of it, so it must be quackery," or, "Ozone is a poisonous gas, and anyone injecting it will be killed."

All the detractors of ozone claim to be "experts", yet they have had no training in any oxidative modality, and there are no studies using correct accepted protocols to prove ozone doesn't work, so it's a mystery how they get away with substituting uneducated opinion for scientific fact in the newspapers.

The establishment "experts" all claim to be "searching for a cure", so why are they so afraid to try, let alone even discuss ozone? Especially with its over 50 years of safe, effective usage on hundreds of thousands of patients. The "old" fights the "new" at every historical pivotal point. REMEMBER. Chiropractic, Psychiatry, and a surgeon washing his hands before he operates on someone, were ALL once labelled as "quackery."

Millions and billions of dollars are being made on treating and researching (not curing) the AIDS plague. As of late 1991, the manufacturer of AZT had made $315 million on sales of it. If humanity continues to choose short term greed or unquestioning reliance upon authority figures as a lifestyle, we'll never be allowed to use medical ozone.

Unless humanity as a whole - and it just might emerge from the direction of the littlest of the "little guys" - finally wakes up and forces the social controllers to let ozone out of the bag, then there will be only widespread sickness and death in every family. Humanity's sins of letting others take responsibility for their own lives will come to visit and live with them. The where will they drive their shiny new car every day? Why, to the AIDS ward and the cemetery.

For now, the oxygen wars continue unabated. The shameful politics and non-responses of our medical system are so bad that even the most unaware are hard pressed to believe we are simply facing a whole bunch of coincidental ignorance and errors.

Government, media and medical bigwigs as a whole continue to strangely ignore and openly disparage the over fifty year history of millions of applications of safe, non-toxic ozone therapy, and, in fact continue to actively use S.W.A.T. teams and jail terms to suppress any further medical ozone research by MDs. People continue to suffer tragically and die needlessly, while many who love their families have their hearts slowly broken watching their significant other waste away. Rumours circulate, and the TV talk shows feature stories about AIDS being some form of planned racial or impersonal genocide to reduce the population.

Due to outright hostility, suppression, or at least non-response by our authorities, desperate people who are facing no alternative to their eventual death from AIDS, cancer or other killers are being forced into the unregulated "ozone underground". In any medical underground, where a therapy is not officially sanctioned or made publicly known, mixed in along with the few shining humanitarians will always be con artist, scams, repression, and yellow journalism. You and your family deserve better that this.

According to the US government, by the year 2000, one out of one will have cancer at some time in their lives. Dr. Robert Strecker estimates 20 million now have AIDS, and that number doubles every two years, maximum. This means that by the year 2000, 320 million people are projected to have AIDS.

It's obvious as the bodies fall around us that the old ways don't work. How long can you afford to continue siding with the old ways before it's your turn at the undertakers cart? Ozone is the only proven potential saviour of humanity with 50 years of safe usage backing it up. It's your choice, do something about this, or continue to ignore the problem until you or someone you love slowly suffers and dies tragically from one of these diseases.

Unless you act, before long I don't see much hope for anybody because EVERYBODY might be in the hospital. There will be no police left to seize ozone machines or "expert" doctors or newsmen left to tell us ozone is "worthless". The authority figures will already be dead or dying from the disease. Wild speculation? This has already happened in countless African towns. We have to stop buying into the illusion that "authority" will save us. This is a part of humanity's great test foretold down through the ages. It is up to you, right now. You are not alone. Help surrounds you. Authority or community? Choose wisely.

Why haven't you heard all of this before? I can't answer for you. It's not for want of trying to reach you for years. Others have tried, and I've personally been on over 700 TV or radio stations, or speaking platforms. TO be heard in this society, no matter how much truth you can deliver, you need a huge political machine that has conditioned everyone to automatically listen to it as authority. We who know the truth about ozone have no such political or media machine.

The special interest machines that do exist have too much invested in their own momentum. That is why we need your help. We aren't getting rich. We only want to allow you the opportunity to save yourself from suffering at the hands of ignorance and greed.
If we join together we will live. We can still turn this thing around.

more info at:
http://www.dreddyclinic.com/integrated_med/ozone-therapy.htm

ClickComments

Balancing Your Hormones Without Drugs... You Can Feel Good Again

Balancing Your Hormones Without Drugs... You Can Feel Good Again

$19.95
[ learn more ]

Add to Cart

Hormone imbalance can be reversed! Look and feel better than ever, just take the time to learn about yourself and read the information contained in this just released e-book about reversing hormone imbalance. Are you ready to finally look and feel great? If so... read on... - E-Book Version.(BH)